Advertisement

Topics

44% of Surveyed Companies Use Health Outcomes Liaisons to Deliver Comparative Effectiveness Data to Payers, According to Cutting Edge Information

20:00 EDT 21 Jul 2015 | Marketwired

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 22, 2015) - New research from pharmaceutical intelligence firm Cutting Edge Information shows that health outcomes liaisons (HOLs) are playing a large role in sharing comparative effectiveness research (CER) with payers. Increasing price-sensitivity in the United States and the Europe is driving groups to find more effective ways of communicating product value to key external stakeholders.

Comparative effectiveness teams at pharmaceutical companies are looking to work closely with HOLs to deliver CER to payers. While managed markets account managers and medical science liaisons still represent the majority of companies to payers, the HOL role is growing and is expected to continue growing.

"HOLs have a specialized skillset that allows them to deliver cohesive comparative effectiveness messages within the larger health economics value story," said Jacob Presson, senior analyst at Cutting Edge Information. "HOLs -- because of their dual financial and clinical background -- are considered more effective communicators of complex comparative effectiveness data."

According to Cutting Edge Information's newest report, "Comparative Effectiveness Research: Value Stories that Engage Patients, Physicians and Payers," the usage of HOLs in comparative effectiveness discussions is now considered a best practice among many top companies and is expected to continue growing. Among smaller companies where the number of HOLs is limited or even nonexistent, companies will train managed markets account managers.

"Comparative Effectiveness Research: Value Stories that Engage Patients, Physicians and Payers," available at http://www.cuttingedgeinfo.com/research/market-access/comparative-effectiveness-research/,
provides metrics on the cost and duration of comparative effectiveness studies, as well as how to best deliver this data to external stakeholders. The report examines the changing priorities with regards to conducting comparative effectiveness research in the US. Highlights include:

For more information about "Comparative Effectiveness Research: Value Stories that Engage Patients, Physicians and Payers," and other health economics related topics, please download the report summary at http://www.cuttingedgeinfo.com/download/?ref=31046.

Image Available: http://www.marketwire.com/library/MwGo/2015/7/20/11G048186/Images/mw19qmij0nc1ek29ml86l1al31r8h2-1396305195545.jpg

CONTACT Rachel Shockley Marketing Team Lead 919-433-0211 NEXT ARTICLE

More From BioPortfolio on "44% of Surveyed Companies Use Health Outcomes Liaisons to Deliver Comparative Effectiveness Data to Payers, According to Cutting Edge Information"

Advertisement
Quick Search
Advertisement
Advertisement